1. Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

   • Walter Jonat
   • Felix Hilpert

   Review 01 February 2006 Pages: 343 - 355

   

2. Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay

   • Soledad Gallego
   • Anna Llort
   • Josep Sanchez de Toledo

   Original Paper 25 January 2006 Pages: 356 - 362

   

3. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes

   • Koji Morohara
   • Yusuke Tajima
   • Mitsuo Kusano

   Original Paper 31 January 2006 Pages: 363 - 375

   

4. Acrokeratosis paraneoplastica of Bazex as an indicator for underlying squamous cell carcinoma of the lung

   • Eva-Susanne Strobel
   • Carolin Bouveret
   • Peter Karl Kohl

   Original Paper 25 January 2006 Pages: 376 - 378

   

5. Intraoperative subcutaneous or intrasplenic vaccination with modified autologous tumor cells leads to enhanced survival in a mouse tumor model

   • Arne Dietrich
   • Christoph Stockmar
   • Johann Hauss

   Original Paper 04 January 2006 Pages: 379 - 388

   

6. The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer

   • G.V. Girish
   • G. Bhattacharya
   • A Kumar Sinha

   Original Paper 21 February 2006 Pages: 389 - 398

   

7. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma

   • Ning Ren
   • Lun-Xiu Qin
   • Zhao-You Tang

   Original Paper 25 February 2006 Pages: 399 - 407

   

8. The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells

   • Sara Marchiani
   • Lorella Bonaccorsi
   • Elisabetta Baldi

   Original Paper 17 February 2006 Pages: 408 - 416